logo
Mosquitoes don't stand a chance against the Thermacell EL55 Mosquito Repeller

Mosquitoes don't stand a chance against the Thermacell EL55 Mosquito Repeller

CNN2 days ago

The Thermacell EL55 Mosquito Repeller is a mosquito-hater's dream. Even though mosquitoes aren't as big of a problem where I live in Colorado, camping in the spring still means I get eaten alive by swarms of the bloodsucking creatures, and I can't stand it.
I wear the best bug sprays while I'm hiking to keep me protected, but I don't like stinking up my entire campsite with DEET when I don't have to. That's why I'm in love with the Thermacell EL55. It's a small device that creates a mosquito-free bubble so you don't have to worry about bites.
Thermacell EL55 Rechargeable Mosquito Repeller and Glow Light
Thermacell's mosquito repellents work great, but this iteration might be the best version yet, thanks to its integrated light. If you're always getting eaten up by mosquitoes at your campsite, this repellent is for you. First things first, the Thermacell actually works. I've tested it on several camping trips, and it does a great job at keeping mosquitoes at bay. However, it is important to note that the Thermacell only repels mosquitoes, not all bugs. So, if you have issues with biting flies or getting bombarded by annoying gnats, you'll have to use regular bug spray.
But if mosquitoes are your issue, the Thermacell works well. I've set it up while camping and just hanging out at the park on multiple occasions, and whenever I use it, I don't notice any mosquitoes hanging around, and I was able to escape my outing bite-free. Plus, the Thermacell barely makes any noise, and the repellent it uses doesn't smell.
The Thermacell EL55 works by heating a cartridge filled with a mosquito repellent. Once heated, the device gently sprays the repellent into the air, creating a cloud with a 1-foot radius, according to Thermacell. The active ingredient in the repellent is metofluthrin, not DEET. But don't worry, it's been proven safe for use around both humans and dogs.
'According to the US Environmental Protection Agency (EPA), metofluthrin exhibits low acute toxicity to mammals when used as directed and is classified as 'practically nontoxic' by oral, dermal and inhalation routes. However, cats are uniquely sensitive to pyrethroids, including metofluthrin,' Karthikeyan Chandrasegaran, an assistant professor of entomology at the University of California, Riverside, said. 'Metofluthrin is generally safe for dogs and other mammals in well-ventilated outdoor settings, but cat owners should exercise caution and avoid indoor or confined use where vapors may accumulate.'
Beyond its safety and efficacy, I also love how easy it is to use. Wherever you are, all you have to do is find a flat surface to rest it on, then press the center button. Lights around the button will flash as the device warms up, then turn solid once the device starts releasing repellent. The instruction manual states that the 20-foot mosquito-free zone can take up to 15 minutes to fully establish. The lights on the device also indicate battery life and charging status.
Speaking of battery life, the EL55 can release repellent for a whopping nine hours, according to Thermacell. When I tested the device's battery life for this product review, it did in fact last right around the advertised nine hours. However, that big number is with the light off. With the light on and the repeller active, the battery life drops to around five and a half hours, which was reflected in my testing.
Repelling mosquitoes is a benefit you can find in the normal Thermacell E55, so why spend the extra $20 and get the one with the light? I like to make my camping checklist as efficient as possible, which means products that perform double or triple duty are a big plus. The lantern built into the EL55 is quite good and can illuminate a picnic table at a campsite or the inside of a tent. It doesn't have all the features of the best camping lanterns, such as additional colors or modes and a hook to hang it, but it's still a solid light. Plus, you can use the features of the EL55 separately or together, which makes it quite versatile.
I would definitely recommend the Thermacell EL55 to campers and anyone who hates being outside with mosquitoes in the summer, but even though I love it, there are some imperfections.
My biggest issue is with its portability. It's small — about the size of a softball — which means it's easy to throw into any bag, but there isn't a way to lock the device so it doesn't accidentally turn on.
One time I went on a camping trip and threw a Thermacell E55 into my camp box. When I showed up to camp and opened the box, the entire (new) repellent cartridge was drained, the battery was dead and my gear was covered in repellent. The repellent capsules come with caps, so you could either put the cap on the cartridge or remove it from the device altogether to avoid contaminating your gear.
However, the Thermacell could still accidentally turn on and drain its battery if not stored carefully. This is especially true with the EL55, since there's a button to turn on the repeller and a separate one to turn on the light. A locking feature is found on most camping lanterns and headlamps to avoid this exact problem, and it's something I'd love to see on Thermacell's next repellents. Even without this feature, you can take the top off the EL55, which prevents the device from turning on, to prevent any drained batteries.
Besides accidentally turning on, the only other thing I don't like about the Thermacell EL55 is its price. Not for the device itself — I think it's well worth $50 — but rather the repellent.
The EL55 comes with one 12-hour cartridge, but replacements cost $20 for 36 more hours or $55 for a three-pack that should last you 120 hours. The longevity of these refills depends on how often you use them, and if you're only turning on your Thermacell for an hour or two a handful of times a month during the summer, the refills might last years. But if you're bringing the EL55 camping and using it for four or five hours every night, you might be buying refills more than you'd like.
Cutter, the brand that makes one of our favorite bug sprays, makes a similar device that also uses metofluthrin as an active ingredient. Because of that, it should have similar efficacy, but I haven't tested it yet. Another alternative people use is citronella candles; however, when we talked to entomologists while researching for our guide on the best bug repellents, they only recommended products with ingredients proven safe and effective by the Centers for Disease Control and Prevention (CDC) and EPA, such as DEET and picaridin.
Of course, wearing bug spray is always an option, but I love how the Thermacell provides protection without making my skin and clothes sticky. Thermacell also has different variations of mosquito repellents, including the original E55, the more rugged EX55, the E65 with a fast-charging base and a few fuel-powered options.
If mosquitoes see you as a free and unlimited blood buffet every evening but you hate bug spray, the Thermacell EL55 is the perfect product for you. It's easy to use, effective and versatile thanks to its built-in light. Refills are expensive, and you should pack the device carefully while traveling, but it's the perfect way to avoid mosquitoes, whether you're hanging out in your backyard or the middle of the woods.
The following FAQs have been answered by Kai Burkhardt, writer of this guide and CNN Underscored's outdoors editor; Adam Goess, the executive director of product development at Thermacell; and Karthikeyan Chandrasegaran, an assistant professor of entomology at the University of California, Riverside.
Are Thermacell's repellents effective?
Are Thermacell's repellents effective?
Yes, Thermacell's mosquito repellents are quite effective. The active ingredient, metofluthrin, has been proven effective at repelling mosquitoes, and when I've set up my Thermacell at camp, mosquitoes have left me alone.
How does Thermacell work?
How does Thermacell work?
The Thermacell mosquito repellents work by heating a cartridge of repellent, then spraying that repellent into the air to create a bubble that mosquitoes stay away from.
Are Thermacell's products safe?
Are Thermacell's products safe?
The active ingredient in Thermacell mosquito repellents, metofluthrin, is classified as 'practically nontoxic' by the EPA. 'However, cats are uniquely sensitive to pyrethroids, including metofluthrin,' Chandrasegaran said. 'Metofluthrin is generally safe for dogs and other mammals in well-ventilated outdoor settings, but cat owners should exercise caution and avoid indoor or confined use where vapors may accumulate.'
Does a Thermacell repel flies?
Does a Thermacell repel flies?
'Thermacell's rechargeable line does not work against flies or gnats; however, our fuel-powered line does offer multi-insect repellent refills for black flies and no-see-ums, in addition to mosquitoes,' Goess said.
Chandrasegaran echoed the same. 'Thermacell devices are highly effective against mosquitoes, but their performance against houseflies is limited,' he said. 'Metofluthrin works by releasing a vapor that disrupts the sensory cues mosquitoes use to find humans. However, houseflies rely more heavily on visual cues and decaying organic matter rather than scent-based host detection. As such, they are less susceptible to spatial repellents like metofluthrin.'
Does a Thermacell work on gnats?
Does a Thermacell work on gnats?
'Biting gnats, such as no-see-ums, are blood-feeding insects that rely on olfactory cues similar to those used by mosquitoes,' Chandrasegaran said. 'Thermacell repellers, which release metofluthrin vapor, may offer moderate protection in these cases. While direct studies on metofluthrin and biting midges are limited, research on transfluthrin — a structurally similar compound — has shown promising results.'
'Thermacell may provide relief from biting gnats, but it is not effective against nonbiting gnats,' Chandrasegaran added. 'For the latter, targeted environmental and biological control strategies are more appropriate.'
How long does a Thermacell last?
How long does a Thermacell last?
According to the brand, the Thermacell EL55 can last up to nine hours if you're only using the repeller and don't turn on the light. The cheaper E55 can last up to five and a half hours, according to Thermacell.
For this article, we consulted the following experts to gain their professional insights.
Karthikeyan Chandrasegaran, assistant professor in the entomology department at the University of California, Riverside
Adam Goess, executive director of product development at Thermacell
CNN Underscored editors thoroughly test most of the products we cover and provide full transparency about how we test them. We have an experienced team of writers and editors with many years of testing experience who ensure each article is carefully edited and products are properly vetted. We talk to top experts when it makes sense to ensure we are testing each product accurately and speaking about the pros and cons of each item.
For this article, outdoors, sustainable living and pets editor Kai Burkhardt spoke to an entomologist and the team at Thermacell to get the lowdown on the device's active ingredient. He also spent time extensively testing the repeller himself while camping and hanging out in parks to give his honest opinion.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

2 Healthcare Stocks to Keep an Eye On and 1 to Ignore
2 Healthcare Stocks to Keep an Eye On and 1 to Ignore

Yahoo

time26 minutes ago

  • Yahoo

2 Healthcare Stocks to Keep an Eye On and 1 to Ignore

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, and over the past six months, the industry has pulled back by 7.5%. This drop was discouraging since the S&P 500 held steady. The elite companies can churn out earnings growth under any circumstance, however, and our mission at StockStory is to help you find them. Taking that into account, here are two healthcare stocks we think can generate sustainable market-beating returns and one we're steering clear of. Market Cap: $4.48 billion Pioneering the shift from bulky, short-term heart monitors to sleek, wire-free patches, iRhythm Technologies (NASDAQ:IRTC) provides wearable cardiac monitoring devices and AI-powered analysis services that help physicians detect and diagnose heart rhythm disorders. Why Is IRTC Not Exciting? Issuance of new shares over the last five years caused its earnings per share to fall by 5.6% annually while its revenue grew Cash-burning history makes us doubt the long-term viability of its business model 124× net-debt-to-EBITDA ratio shows it's overleveraged and increases the probability of shareholder dilution if things turn unexpectedly iRhythm's stock price of $138.38 implies a valuation ratio of 78.4x forward EV-to-EBITDA. If you're considering IRTC for your portfolio, see our FREE research report to learn more. Market Cap: $3.51 billion Pioneering treatments for a devastating childhood muscle-wasting disease that primarily affects boys, Sarepta Therapeutics (NASDAQ:SRPT) develops and commercializes RNA-targeted therapies and gene therapies for rare genetic disorders, primarily Duchenne muscular dystrophy. Why Do We Love SRPT? Market share has increased this cycle as its 51.3% annual revenue growth over the last two years was exceptional Earnings per share grew by 41% annually over the last five years, massively outpacing its peers Cash-burning tendencies have improved over the last five years, showing it could become financially independent one day At $35.74 per share, Sarepta Therapeutics trades at 3.5x forward P/E. Is now a good time to buy? See for yourself in our comprehensive research report, it's free. Market Cap: $14.82 billion With a network spanning nine states and serving primarily urban and suburban communities, Tenet Healthcare (NYSE:THC) operates a nationwide network of hospitals, ambulatory surgery centers, and outpatient facilities providing acute care and specialty healthcare services. Why Do We Like THC? Share repurchases have amplified shareholder returns as its annual earnings per share growth of 30.7% exceeded its revenue gains over the last five years Market-beating returns on capital illustrate that management has a knack for investing in profitable ventures, and its returns are growing as it capitalizes on even better market opportunities Returns on capital are climbing as management makes more lucrative bets Tenet Healthcare is trading at $159.57 per share, or 13x forward P/E. Is now the right time to buy? Find out in our full research report, it's free. The market surged in 2024 and reached record highs after Donald Trump's presidential victory in November, but questions about new economic policies are adding much uncertainty for 2025. While the crowd speculates what might happen next, we're homing in on the companies that can succeed regardless of the political or macroeconomic environment. Put yourself in the driver's seat and build a durable portfolio by checking out our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 176% over the last five years. Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today for free. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data

Sarepta reports outcomes from trial of Duchenne muscular dystrophy therapy
Sarepta reports outcomes from trial of Duchenne muscular dystrophy therapy

Yahoo

time26 minutes ago

  • Yahoo

Sarepta reports outcomes from trial of Duchenne muscular dystrophy therapy

Sarepta Therapeutics has announced new outcomes from its open-label Phase Ib Study 9001-103, also referred to as the ENDEAVOR trial, of adeno-associated virus (AAV)-based gene transfer therapy Elevidys (delandistrogene moxeparvovec-rokl) to treat Duchenne muscular dystrophy (DMD). The multi-cohort ENDEAVOR study is aimed at evaluating the therapy's safety and protein expression in male subjects with DMD. Across seven cohorts, the trial enrolled 55 subjects and dosed participants who were aged between four and seven years old at the time of treatment, with varying degrees of mobility, and those younger than four years old. The primary endpoint of the trial is the change from baseline in Elevidys micro-dystrophin protein expression quantity at 12 weeks, as per western blot measurement, with secondary outcomes measuring dystrophin-positive fibres. In addition, the trial's exploratory endpoints evaluate the change in vector genome copies per nucleus, the North Star Ambulatory Assessment (NSAA), and timed functional tests. Inclusive of the first 12-week duration, subjects will undergo a follow-up period of a total of five years. In cohort 6, subjects aged two years old at the time of treatment showed a mean expression of 93.87% of normal dystrophin levels when treated with the therapy, with 79.9% dystrophin-positive fibres. These outcomes were observed in biopsies 12 weeks post-treatment. The safety seen in this cohort was found to be in line with the clinical and real-world applications of the therapy. Sarepta noted that the company has shared safety and expression from the trial's cohort 4, in which subjects were aged three at the time of treatment and showed a mean protein level of 99.64% in biopsies taken at the same post-treatment interval. More than 25 subjects below four years of age were treated in Sarepta's clinical trials. Sarepta Therapeutics research and development head and chief scientific officer Louise Rodino-Klapac said: 'The strength of the biomarker results that we are seeing in younger patients is extremely encouraging, and we have a meeting with the US Food and Drug Administration next month to discuss expanding the Elevidys label to include younger patients.' Last December, Sarepta completed enrolment and dosing for the Phase III EMERGENE trial of SRP-9003 (bidridistrogene xeboparvovec), targeting limb-girdle muscular dystrophy Type 2E/R4. "Sarepta reports outcomes from trial of Duchenne muscular dystrophy therapy" was originally created and published by Clinical Trials Arena, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store